#pregnancy

A new study found such young people typically hit standard adult milestones but often experience serious life challenges.

A large ongoing study in Botswana has found that about 1 in 150 babies exposed to Tivicay at conception developed such birth defects.

However, various disparities based on race and insurance type persist.

A recent study compared birth outcomes among HIV-positive women exposed to various antiretroviral regimens.

The integrase inhibitor is included in the single-tablet HIV regimens Triumeq and Juluca.

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

Continuously providing such infants with antiretrovirals as early as possible limits the size of the reservoir.

Saturday, March 10, is a day to say #ICanStopHIV!

According to recent studies, this shift in risk is likely driven by biological, and not just behavioral, factors.

Nevertheless, the benefits of HIV treatment for both the mother and unborn child far outweigh any such risk.

However, the analysis that identified this connection is subject to various limitations.

A recent study found that hep C was also associated with an increased risk of miscarriage.

Unlike the World Health Organization’s public health guidelines, these are centered on the individual.

Six percent of a group of pregnant Canadian women saw their virus rise to detectable levels close to delivery.

A recent analysis helped shed light on the stillborn rate among those living in wealthier nations.